1. Home
  2. ATYR vs LOAN Comparison

ATYR vs LOAN Comparison

Compare ATYR & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.53

Market Cap

50.9M

Sector

Health Care

ML Signal

HOLD

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

HOLD

Current Price

$4.23

Market Cap

48.2M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
LOAN
Founded
2005
1989
Country
United States
United States
Employees
58
6
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
50.9M
48.2M
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
ATYR
LOAN
Price
$0.53
$4.23
Analyst Decision
Hold
Analyst Count
9
0
Target Price
$3.67
N/A
AVG Volume (30 Days)
4.1M
24.3K
Earning Date
05-01-2026
04-16-2026
Dividend Yield
N/A
10.06%
EPS Growth
N/A
N/A
EPS
N/A
0.11
Revenue
N/A
$8,666,307.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$38.05
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$4.13
52 Week High
$7.29
$5.85

Technical Indicators

Market Signals
Indicator
ATYR
LOAN
Relative Strength Index (RSI) 41.87 42.95
Support Level $0.40 $4.14
Resistance Level $0.86 $4.48
Average True Range (ATR) 0.08 0.08
MACD -0.01 0.01
Stochastic Oscillator 23.15 27.50

Price Performance

Historical Comparison
ATYR
LOAN

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

Share on Social Networks: